Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 167-172

  Hodgson, Jonathan M ^a   Puddey, Ian B ^a   Croft, Kevin D ^a   Mori, Trevor A ^a   Rivera, Jennifer ^a   Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antioxidant; Blood pressure; Genistein; Isoflavonoids; Isoprostanes

Indexed keywords

CREATININE; DAIDZEIN; GENISTEIN; ISOFLAVONOID; ISOPROSTANE; LIPID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; URINARY EXCRETION;

ADULT; AGED; ANTIOXIDANTS; BLOOD PRESSURE; CREATININE; DINOPROST; DOUBLE-BLIND METHOD; FEMALE; GENISTEIN; HUMANS; HYPERTENSION; ISOFLAVONES; LIPID PEROXIDATION; MALE; MIDDLE AGED;

EID: 0033042368     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00029-5     Document Type: Article

References (35)

1. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
2. Romero-Alvira D., Roche E. High blood pressure, oxygen radicals and antioxidants: etiological relationships. Med. Hypoth. 46:1996;414-420.
3. Ferro C.J., Webb D.J. Endothelial dysfunction and hypertension. Drugs. 53:1997;30-41.
4. Setchell K.D.R., Adlercreutz H. Mammalian lignans and phyto-oestrogens: recent studies on their formation, metabolism and biological role in health and disease. Rowland I.R. Role of Gut Flora in Toxicity and Cancer. 1988;315-345 Academic Press, San Diego, CA.
5. Kapioitis S., Hermann M., Held I., Seelos C., Ehringer H., Gmeiner B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17:1997;2868-2874.
6. Record I.R., Dreosti I.E., McInerney J.K. The antioxidant activity of genistein in vitro. J. Nutr. Biochem. 6:1995;481-485.
7. Ruiz-Larrea M.B., Mohan A.R., Pagana G., Miller N.J., Bolwell G.P., Rice-Evans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free. Rad. Res. 26:1997;63-70.
8. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995; 208:124-130.
9. Hodgson J.M., Croft K.D., Puddey I.B., Mori T.A., Beilin L.J. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J. Nutr. Biochem. 7:1996;664-669.
10. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free. Rad. Res. 25:1996;57-74.
11. Morrow J.D., Roberts L.J. The isoprostanes: current knowledge and directions for future research. Biochem. Pharmacol. 51:1996;1-9.
12. Morrow J.D., Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid. Res. 36:1997;1-21.
13. Patrono C., FitzGerald G.A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;2309-2315.
14. 2-isoprostanes in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation). J. Clin. Invest. 90:1992;2502-2507.
15. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
16. 2α is increased in hypercholesterolaemia. Arterioscler. Thromb. Vasc. Biol. 17:1997;3230-3235.
17. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:1995;225-229.
18. 2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100:1997;2028-2034.
19. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Burke V, Croft KD, Rogers P. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomised controlled trial. Am J Hypertens 1999;121:47-52.
20. 2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1998;268:117-125.
21. Franke A.A., Custer L.J., Cerna C.M., Narla K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc. Exp. Biol. Med. 208:1995;18-26.
22. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 85:1992;1927-1938.
23. Briner V.A., Luscher T. Role of vascular endothelial abnormalities in clinical medicine: atherosclerosis, hypertension, diabetes and endotoxaemia. Adv. Int. Med. 39:1994;910-915.
24. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 96:1997;1513-1519.
25. Nestel P.J., Yamashita T., Sasahara T. et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17:1997;3392-3398.
26. Ness A.R., Chee D., Elliott P. Vitamin C and blood pressure - an overview. J. Hum. Hypertens. 11:1997;343-350.
27. Ceriello A., Giugliano D., Quatraro A., Lefebvre P.J. Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin. Sci. 81:1991;739-742.
28. Galley H.F., Thornton J., Howdle P.D., Walker B.E., Webster N.R. Combination oral antioxidant supplementation reduces blood pressure. Clin. Sci. 92:1997;361-365.
29. Osilesi O., Trout D.L., Ogunwole J.O., Glover E.E. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adilts. Nutr. Res. 11:1991;405-412.
30. Ghosh S.K., Ekpo E.B., Shah I.U., Girling A.J., Jenkins C., Sinclair A.J. A double-blind placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerentology. 40:1994;268-272.
31. Lovat L.B., Lu Y., Palmer A.J., Edwards R., Fletcher A.E., Bullpit C.J. Double-blind trial of vitamin C in elderly hypertensives. J. Hum. Hypertens. 7:1993;403-405.
32. Miller E.R., Appel L.J., Levander O.A., Levine D.M. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J. Cardiovasc. Risk. 4:1997;19-24.
33. Messina M. Isoflavone intakes by Japanese were overestimated. Am J Clin Nutr 1995; 62:645. Comment on: Am J Clin Nutr 1995; 60: 333-340.
34. Messina M. Isoflavone intakes by Japanese were overestimated. Am J Clin Nutr 1995; 62:645. Comment on: Am J Clin Nutr 1995; 60: 333-340.
35. Xu X., Wang H., Murphy P.A., Cook L., Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124:1994;825-832.